In an effort to eliminate nearly 40,000 new HIV infections in the U.S. each year, the U.S. Preventive Services Task Force recommended Truvada, which can reduce the risk of infection by 92% when taken daily, should be offered to more patients. High cost has been a barrier, and so far fewer than 10% of high-risk people take the medication.
from Kaiser Health News http://bit.ly/2Zof8KJ
June 12, 2019
Rose
Health News, Kaiser Health News
No comments
Related Posts:
Why Doctors Keep Monitoring Kids Who Recover From Mysterious COVID-Linked IllnessIsrael Shippy doesn’t remember much about having COVID-19 — or the unusual auto-immune disease it triggered — other than being groggy and uncomfortable for a bunch of days. He’s a 5-year-old, and would much rather talk about … Read More
A Coronavirus Vaccine: Where Does It Stand?More than four months into the coronavirus pandemic, how close are the U.S. and the world to a safe and effective vaccine? Scientists say they see steady progress and are expressing cautious optimism that a vaccine could be r… Read More
Más allá de teorías conspirativas, éste es el trabajo de los rastreadores de contactos Use Nuestro Contenido Este contenido puede usarse de manera gratuita (detalles). En medio de la pandemia de COVID-19, el rastreo de contactos es objeto de comentarios positivos… y algunos negativos. El rastreo de cont… Read More
Conspiracy Theories Aside, Here’s What Contact Tracers Really DoIn the midst of the COVID-19 epidemic, contact tracing is downright buzzy, and not always in a good way. Contact tracing is the public health practice of informing people when they’ve been exposed to a contagious disease. As … Read More
California School Districts Grope for Sensible Reopening PlansSchool leaders in Elk Grove, California, wanted to leave as little to chance as possible. So they brought nearly 150 voices into their decision-making process, and canvassed the parents of the estimated 63,000 students in the… Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment